OrbiMed Advisors LLC's Form 4 filing
Passage BIO, Inc. (PASG) · filed Jan 20, 2022
- Accession no.
- 0000947871-22-000086
- Filed
- Jan 20, 2022, 6:03 PM ET
- Trade date
- Jan 14-19, 2022
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $905.2K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2022 | Common Stock | PPurchaseAcquired | +10,300 | $5.60F1 | +$57,680 | 6,107,623 | Indirect | |
| Jan 18, 2022 | Common Stock | PPurchaseAcquired | +114,700 | $5.46F3 | +$626,262 | 6,222,323 | Indirect | |
| Jan 19, 2022 | Common Stock | PPurchaseAcquired | +43,300 | $5.11F4 | +$221,263 | 6,265,623 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of the Issuer's common stock ("Shares") were purchased in a block order at price of $5.60.
Referenced by the price of 1 transaction in Table I.
- F3
These Shares were purchased in a block order at price of $5.46.
Referenced by the price of 1 transaction in Table I.
- F4
These Shares were purchased in a block order at price of $5.11.
Referenced by the price of 1 transaction in Table I.